Javier Rejas-Gutiérrez

Summary

Affiliation: Pfizer Global Research and Development
Country: USA

Publications

  1. pmc The assessment of generalized anxiety disorder: psychometric validation of the Spanish version of the self-administered GAD-2 scale in daily medical practice
    Javier Garcia-Campayo
    Department of Psychiatry, Hospital Miguel Servet, Zaragoza, 50009, Spain
    Health Qual Life Outcomes 10:114. 2012
  2. pmc Dose and aging effect on patients reported treatment benefit switching from the first overactive bladder therapy with tolterodine ER to fesoterodine: post-hoc analysis from an observational and retrospective study
    David Castro-Diaz
    Department of Urology, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain
    BMC Urol 12:19. 2012
  3. doi request reprint Detecting changes in patient treatment satisfaction with medicines: the SATMED-Q
    Javier Rejas
    Health Economics and Outcomes Research Department, Pfizer, S L U, Alcobendas, Madrid, Spain
    Value Health 16:88-96. 2013
  4. pmc A confirmatory study of the Combined Index of Severity of Fibromyalgia (ICAF*): factorial structure, reliability and sensitivity to change
    Miguel A Vallejo
    Facultad de Psicologia, Universidad Nacional de Educacion a Distancia, Madrid, Spain
    Health Qual Life Outcomes 9:39. 2011
  5. pmc Clinical usefulness of the screen for cognitive impairment in psychiatry (SCIP-S) scale in patients with type I bipolar disorder
    Georgina Guilera
    Department of Methodology, Faculty of Psychology, University of Barcelona, Barcelona, Spain
    Health Qual Life Outcomes 7:28. 2009
  6. pmc Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study
    Pilar Carrasco Garrido
    Preventive Medicine and Public Health Department, Universidad Rey Juan Carlos, Alcorcon, Madrid, Spain
    Health Qual Life Outcomes 4:31. 2006
  7. pmc Cultural adaptation into Spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool
    Javier Garcia-Campayo
    Department of Psychiatry, Hospital Universitario Miguel Servet, Zaragoza, Spain
    Health Qual Life Outcomes 8:8. 2010
  8. pmc Validity and reliability of the Spanish version of the DN4 (Douleur Neuropathique 4 questions) questionnaire for differential diagnosis of pain syndromes associated to a neuropathic or somatic component
    Concepcion Perez
    Unit of Pain, Hospital de la Princesa, Madrid, Spain
    Health Qual Life Outcomes 5:66. 2007
  9. pmc Cost-effectiveness analysis of antimuscarinics in the treatment of patients with overactive bladder in Spain: a decision-tree model
    Salvador Arlandis-Guzman
    Department of Urology, Hospital Universitario La Fe, Valencia, Spain
    BMC Urol 11:9. 2011
  10. pmc A cost-consequences analysis of the effect of pregabalin in the treatment of peripheral neuropathic pain in routine medical practice in primary care settings
    Ana Navarro
    Primary Care Health Centre Puerta del Ángel, Madrid, Spain
    BMC Neurol 11:7. 2011

Collaborators

Detail Information

Publications53

  1. pmc The assessment of generalized anxiety disorder: psychometric validation of the Spanish version of the self-administered GAD-2 scale in daily medical practice
    Javier Garcia-Campayo
    Department of Psychiatry, Hospital Miguel Servet, Zaragoza, 50009, Spain
    Health Qual Life Outcomes 10:114. 2012
    ..To psychometrically validate the Spanish version of the self-administered 2-item GAD-2 scale for screening probable patients with generalised anxiety disorder (GAD)...
  2. pmc Dose and aging effect on patients reported treatment benefit switching from the first overactive bladder therapy with tolterodine ER to fesoterodine: post-hoc analysis from an observational and retrospective study
    David Castro-Diaz
    Department of Urology, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain
    BMC Urol 12:19. 2012
    ..This study aimed to assess the effect of aging and dose escalation on patient-reported treatment benefit, after changing their first Overactive Bladder (OAB) therapy with tolterodine-ER to fesoterodine in daily clinical practice...
  3. doi request reprint Detecting changes in patient treatment satisfaction with medicines: the SATMED-Q
    Javier Rejas
    Health Economics and Outcomes Research Department, Pfizer, S L U, Alcobendas, Madrid, Spain
    Value Health 16:88-96. 2013
    ..Responsiveness (sensitivity to change) and known-group validity, however, still remained unknown. Thus, the goal of this study was to explore such psychometric properties for the SATMED-Q...
  4. pmc A confirmatory study of the Combined Index of Severity of Fibromyalgia (ICAF*): factorial structure, reliability and sensitivity to change
    Miguel A Vallejo
    Facultad de Psicologia, Universidad Nacional de Educacion a Distancia, Madrid, Spain
    Health Qual Life Outcomes 9:39. 2011
    ....
  5. pmc Clinical usefulness of the screen for cognitive impairment in psychiatry (SCIP-S) scale in patients with type I bipolar disorder
    Georgina Guilera
    Department of Methodology, Faculty of Psychology, University of Barcelona, Barcelona, Spain
    Health Qual Life Outcomes 7:28. 2009
    ..This investigation assessed the psychometric properties of the Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S) for the detection of cognitive impairment in BD...
  6. pmc Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study
    Pilar Carrasco Garrido
    Preventive Medicine and Public Health Department, Universidad Rey Juan Carlos, Alcorcon, Madrid, Spain
    Health Qual Life Outcomes 4:31. 2006
    ..The aim of this work is to assess the Health-Related Quality of Life (HRQoL) of patients with stable COPD followed in primary care and to identify possible predictors of disease...
  7. pmc Cultural adaptation into Spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool
    Javier Garcia-Campayo
    Department of Psychiatry, Hospital Universitario Miguel Servet, Zaragoza, Spain
    Health Qual Life Outcomes 8:8. 2010
    ..This study carried out the cultural adaptation into Spanish of the 7-item self-administered GAD-7 scale, which is used to identify probable patients with GAD...
  8. pmc Validity and reliability of the Spanish version of the DN4 (Douleur Neuropathique 4 questions) questionnaire for differential diagnosis of pain syndromes associated to a neuropathic or somatic component
    Concepcion Perez
    Unit of Pain, Hospital de la Princesa, Madrid, Spain
    Health Qual Life Outcomes 5:66. 2007
    ..This study assesses the validity and reliability of the Spanish version of DN4 questionnaire as a tool for differential diagnosis of pain syndromes associated to a neuropathic (NP) or somatic component (non-neuropathic pain, NNP)...
  9. pmc Cost-effectiveness analysis of antimuscarinics in the treatment of patients with overactive bladder in Spain: a decision-tree model
    Salvador Arlandis-Guzman
    Department of Urology, Hospital Universitario La Fe, Valencia, Spain
    BMC Urol 11:9. 2011
    ..The purpose of this analysis was to assess the economic value of OAB treatment with fesoterodine relative to extended release tolterodine and solifenacin, from the societal perspective...
  10. pmc A cost-consequences analysis of the effect of pregabalin in the treatment of peripheral neuropathic pain in routine medical practice in primary care settings
    Ana Navarro
    Primary Care Health Centre Puerta del Ángel, Madrid, Spain
    BMC Neurol 11:7. 2011
    ....
  11. pmc New uses of the Migraine Screen Questionnaire (MS-Q): validation in the Primary Care setting and ability to detect hidden migraine. MS-Q in Primary Care
    Miguel J Láinez
    Department of Neurology, University Hospital of Valencia, Valencia, Spain
    BMC Neurol 10:39. 2010
    ..The aim of the study was to validate the self-administered MS-Q questionnaire for detection of hidden migraine in the field of primary care (PC), and to explore its use in this setting...
  12. pmc Cognitive impairment in patients with fibromyalgia syndrome as assessed by the mini-mental state examination
    Jose Rodríguez-Andreu
    Department of Rheumatology, Hospital Virgen de la Victoria, Malaga, Spain
    BMC Musculoskelet Disord 10:162. 2009
    ..This study evaluated the frequency of cognitive impairment in patients with Fibromyalgia syndrome (FMS) using the Mini Mental State Examination (MMSE)...
  13. pmc Use of aspirin for primary and secondary prevention of cardiovascular disease in diabetic patients in an ambulatory care setting in Spain
    Antoni Sicras-Mainar
    Badalona Serveis Assistencials SA, Badalona, Barcelona, Spain
    BMC Fam Pract 8:60. 2007
    ..This study was conducted in order to determine the use of aspirin and to assess the achievement of therapeutic targets in diabetic patients according to primary (PP) or secondary prevention (SP)...
  14. ncbi request reprint Concordance of standard and modified NCEP ATP III criteria for identification of metabolic syndrome in outpatients with schizophrenia treated with antipsychotics: a corollary from the CLAMORS study
    Javier Rejas
    Health Outcomes Research Department, Medical Unit, Pfizer España, Ava de Europa, 20 B, 28108, Alcobendas Madrid, Spain
    Schizophr Res 99:23-8. 2008
    ..To analyze the concordance between standard and modified NCEP-ATP-III criteria for identification of metabolic syndrome (MS) in outpatients with schizophrenia...
  15. ncbi request reprint [Standard error of measurement: an alternative to minimally important difference to access changes in patient-reported-health-outcomes]
    J Rejas
    Departamento de Investigación de Resultados en Salud, Unidad Médica Pfizer España, Alcobendas, Madrid
    An Med Interna 24:415-20. 2007
    ..To assess the concordance level between the standard Error of Measurement (EEM) and the minimal important difference (MID) criteria when evaluating the magnitude of change in self-perceived health status due to a clinical intervention...
  16. doi request reprint Criterion validity of the ARthritis Treatment Satisfaction (ARTS) questionnaire: patient satisfaction with treatment and need for switching therapy
    Javier Rejas
    Health Outcomes Research Department, Medical Unit, Pfizer Spain, Alcobendas Madrid, Spain
    Clin Drug Investig 29:527-38. 2009
    ....
  17. doi request reprint Standard error of measurement as a valid alternative to minimally important difference for evaluating the magnitude of changes in patient-reported outcomes measures
    Javier Rejas
    Department of Pharmacoeconomics and Health Outcomes Research, Medical Unit, Pfizer Spain
    J Clin Epidemiol 61:350-6. 2008
    ..To assess the degree of agreement between standard error of measurement (SEM) and minimally important difference (MID) criteria to evaluate the magnitude of the change caused by a medical intervention...
  18. ncbi request reprint Psychometric properties of the MOS (Medical Outcomes Study) Sleep Scale in patients with neuropathic pain
    Javier Rejas
    Health Outcomes Research Department, Medical Unit, Pfizer España, Madrid, Spain
    Eur J Pain 11:329-40. 2007
    ..This study assessed the psychometric properties of the MOS Sleep Scale in neuropathic pain (NeP)...
  19. pmc Minimally important difference of the Treatment Satisfaction with Medicines Questionnaire (SATMED-Q)
    Javier Rejas
    Health Outcomes Research Department, Corporate Affairs and Market Access Unit, Pfizer España, Alcobendas, Madrid, Spain
    BMC Med Res Methodol 11:142. 2011
    ..The objective of this research was to estimate the MID for the SATMED-Q total score and six constituent domains...
  20. ncbi request reprint [Sensitivity to change and minimally important difference of the Spanish version of the life-satisfaction questionnaire LISAT-8 in male patients with erectile dysfunction]
    Javier Rejas
    Departamento de Farmacoepidemiología y Farmacovigilancia, Unidad Médica, Pfizer S A, Madrid, Spain
    Med Clin (Barc) 124:165-71. 2005
    ..We determined the sensitivity to change and minimally important difference (MID) of the Spanish version of the life-satisfaction check list LISAT-8...
  21. doi request reprint Inappropriate overuse of inhaled corticosteroids for COPD patients: impact on health costs and health status
    Javier de Miguel-Díez
    Pneumology Department, Hospital General Universitario Gregorio Maranon, Doctor Esquerdo, 46, 28007, Madrid, Spain
    Lung 189:199-206. 2011
    ..Factors statistically associated with inappropriate use of corticosteroids were educational attainment, a history of heart disease, depression, any allergy, and physical health status...
  22. pmc The influence of heart disease on characteristics, quality of life, use of health resources, and costs of COPD in primary care settings
    Javier de Miguel-Díez
    Department of Pneumology, Hospital General Universitario Gregorio Maranon, Madrid, Spain
    BMC Cardiovasc Disord 10:8. 2010
    ..To evaluate the influence of heart disease on clinical characteristics, quality of life, use of health resources, and costs of patients with COPD followed at primary care settings under common clinical practice conditions...
  23. doi request reprint Health, treatment and health care resources consumption profile among Spanish adults with diabetes and chronic obstructive pulmonary disease
    Rodrigo Jimenez-Garcia
    Unidad de Docencia e Investigacion en Medicina Preventiva y Salud Publica, Facultad de Ciencias de la Salud, Avda de Atenas s n, 28922 Alcorcon, Madrid, Spain
    Prim Care Diabetes 3:141-8. 2009
    ..To describe the health, treatment and health care resources consumption profile among Spanish adults with diabetes and chronic obstructive pulmonary disease (COPD), and compare it with that of non-diabetic COPD patients...
  24. ncbi request reprint Patient-reported outcomes in subjects with painful trigeminal neuralgia receiving pregabalin: evidence from medical practice in primary care settings
    C Perez
    Pain Clinics, University Hospital La Princesa, Madrid, Spain
    Cephalalgia 29:781-90. 2009
    ..6 +/- 22.2 mm (ES 1.67; P < 0.0001), with 0.0388 +/- 0.0374 gained quality-adjusted life-years. In spite of the small sample size, results support the effectiveness of PGB for the improvement in pain and related health symptoms...
  25. doi request reprint Pregabalin and gabapentin in matched patients with peripheral neuropathic pain in routine medical practice in a primary care setting: Findings from a cost-consequences analysis in a nested case-control study
    Concepcion Perez
    Hospital Universitario de la Princesa, Madrid, Spain
    Clin Ther 32:1357-70. 2010
    ..Pregabalin and gabapentin are marketed to treat peripheral neuropathic pain, but head-to-head comparison is lacking...
  26. ncbi request reprint Prospective study of the use of healthcare resources and economic costs in patients with fibromyalgia after treatment in routine medical practice
    Javier Rivera
    Rheumatology Unit, Instituto Provincial de Rehabilitación, Hospital General Universitario Gregorio Maranon, Madrid, Spain
    Clin Exp Rheumatol 30:31-8. 2012
    ..To estimate the burden and to prospectively analyse resources utilisation and costs in a cohort of treated patients with fibromyalgia (FM) in daily practice...
  27. ncbi request reprint Resource utilisation and health care costs in patients diagnosed with fibromyalgia in Spain
    J Rivera
    Unidad de Reumatologia, Instituto Provincial de Rehabilitación, Hospital General Universitario Gregorio Maranon, Madrid, Spain
    Clin Exp Rheumatol 27:S39-45. 2009
    ..The aim of this study is to describe health care resource utilisation and related costs of FM from the perspective of the National Health System in Spain...
  28. ncbi request reprint Cost-effectiveness analysis of ziprasidone versus haloperidol in sequential intramuscular/oral treatment of exacerbation of schizophrenia: economic subanalysis of the ZIMO trial
    Fernando Cañas
    Department of Psychiatry, Hospital Rodríguez Lafora, Madrid, Spain
    Clin Drug Investig 27:633-45. 2007
    ..This study aimed to assess the cost effectiveness of ziprasidone versus haloperidol in sequential intramuscular (IM)/oral treatment of patients with exacerbation of schizophrenia in Spain...
  29. doi request reprint A comparison of schizophrenia outpatients treated with antipsychotics with and without metabolic syndrome: findings from the CLAMORS study
    Celso Arango
    Psychiatry Department, Hospital General Universitario Gregorio Marañón and Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid, Spain
    Schizophr Res 104:1-12. 2008
    ..To compare clinical, laboratory, lifestyle, and sociodemographic parameters and cardiac risk in antipsychotic-treated patients with and without metabolic syndrome (MS)...
  30. ncbi request reprint [Linguistic adaptation into Spanish and validation of the Arthritis Treatment Satisfaction Questionnaire]
    Miguel Ruiz
    Departamento de Metodologia, Facultad de Psicologia, Universidad Autonoma, Madrid, Spain
    Med Clin (Barc) 125:84-92. 2005
    ....
  31. doi request reprint Development and validation of the "Treatment Satisfaction with Medicines Questionnaire" (SATMED-Q)
    Miguel A Ruiz
    Department of Methodology, School of Psychology, Madrid Autonomous University, Madrid, Spain
    Value Health 11:913-26. 2008
    ..To develop and validate a multidimensional generic questionnaire measuring satisfaction with treatment with medicines. The questionnaire was designed to be used in chronic patients undergoing pharmacological treatment for any disease...
  32. pmc Characteristics of chronic obstructive pulmonary disease in Spain from a gender perspective
    Pilar Carrasco-Garrido
    School of Health Sciences, Universidad Rey Juan Carlos, Alcorcon, Madrid, Spain
    BMC Pulm Med 9:2. 2009
    ..The objective of this study was to analyze the clinical and management characteristics of chronic obstructive pulmonary disease (COPD) in men and women, to determine possible gender-associated differences between the two groups of patients...
  33. ncbi request reprint [Validation of the Spanish version of the SEAR (Self-Esteem And Relationship Questionnaire) for men with erectile dysfunction]
    Javier Rejas-Gutiérrez
    Departamento de Farmacoepidemiología y Farmacoeconomía, Unidad Médica Pfizer España, Alcobendas, Madrid, Spain
    Med Clin (Barc) 125:565-73. 2005
    ....
  34. ncbi request reprint [Clinical prevalence and reason for visit of patients with generalized anxiety disorder seen in the psychiatry out-patient clinics in Spain. Results of the LIGANDO study]
    L Caballero
    Psychiatry Department, Hospital Puerta de Hierro, Madrid, Spain
    Actas Esp Psiquiatr 37:17-20. 2009
    ..Its prevalence in the general population and in primary care has been established previously in Spain; however it still must be determined in the mental health...
  35. ncbi request reprint Erectile dysfunction in a primary care setting: results of an observational, no-control-group, prospective study with sildenafil under routine conditions of use
    A Gil
    Department of Health Sciences, University Rey Juan Carlos, , Madrid, Spain
    Int J Impot Res 13:338-47. 2001
    ..The adverse events occurring were similar to those seen in clinical research on sildenafil in the premarketing phase. No control group was included in this study...
  36. doi request reprint Patient-reported outcomes in subjects with neuropathic pain receiving pregabalin: evidence from medical practice in primary care settings
    Ana Navarro
    Primary Care Health Centre Puerta del Ángel, Madrid, Spain
    Pain Med 11:719-31. 2010
    ..To evaluate the effect of pregabalin on different patient-reported outcomes in subjects with neuropathic pain treated under usual medical practice conditions in primary care settings...
  37. ncbi request reprint Linguistic adaptation and validation into Spanish of the Diagnostic Interview for Borderline Personality Disorders-Revised (DIB-R)
    Néstor Szerman
    Moratalaz Mental Health Centre, Madrid, Spain
    Curr Med Res Opin 21:1251-9. 2005
    ..This paper describes the linguistic adaptation and psychometric validation into Spanish of the Diagnostic Interview for Borderlines-Revised (DIB-R) scale for diagnosing borderline personality disorder (BPD)...
  38. doi request reprint Trigeminal neuralgia treated with pregabalin in family medicine settings: its effect on pain alleviation and cost reduction
    Concepcion Perez
    Unidad del Dolor, Hospital de la Princesa, C Diego de Leon, Madrid, Spain
    J Clin Pharmacol 49:582-90. 2009
    ..001) and indirect costs (-euro 1210 +/- 1141, P < .001). It is concluded that PGB as monotherapy or combined with other drugs is effective in pain management in patients with trigeminal neuralgia and reduces the cost of illness...
  39. doi request reprint Prospective one-year cost-of-illness study in a cohort of patients with dementia of Alzheimer's disease type in Spain: the ECO study
    Alicia Coduras
    Gaspar Casal Foundation, Madrid, Spain
    J Alzheimers Dis 19:601-15. 2010
    ..In conclusion, monthly overall mean cost of dementia of AD type was high in Spain (1,412.73 euro). Almost 88% of the cost-of-illness is funded by the patient's own family, adding a financial burden to the suffering of these families...
  40. doi request reprint Prevalence and characterization of neuropathic pain in a primary-care setting in Spain: a cross-sectional, multicentre, observational study
    Concepcion Perez
    Pain Clinic, University Hospital La Princesa, Madrid, Spain
    Clin Drug Investig 29:441-50. 2009
    ..In Spain there are no recent data on the prevalence and management of neuropathic pain in the general primary-care setting...
  41. ncbi request reprint A pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes in Spain
    Juan Antonio Gómez-Gerique
    Clinic Biochemistry Department, Hospital Fundación Jiménez Díaz, Madrid, Spain
    Eur J Health Econ 5:278-84. 2004
    ..In Spain, the intensive short-term use of atorvastatin in patients with ACS has a favorable cost-effectiveness. The direct cost of the drug was largely offset by the associated reduction in costs for treating fewer cardiovascular events...
  42. ncbi request reprint Length of stay and antipsychotic treatment costs of patients with acute psychosis admitted to hospital in Spain. Description and associated factors. The Psychosp study
    Salvador Peiró
    Fundación Instituto de Investigación en Servicios de Salud, San Vicente 112, 3, 46007, Valencia, Spain
    Soc Psychiatry Psychiatr Epidemiol 39:507-13. 2004
    ....
  43. ncbi request reprint Economic consequences of the adverse reactions related with antipsychotics: an economic model comparing tolerability of ziprasidone, olanzapine, risperidone, and haloperidol in Spain
    Julio Bobes
    Department of Psychiatry, University of Oviedo, Oviedo, Spain
    Prog Neuropsychopharmacol Biol Psychiatry 28:1287-97. 2004
    ..These results should be taken into account by health decision makers and clinicians in the management of patients with schizophrenia...
  44. doi request reprint Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database
    Antoni Sicras
    Badalona Serveis Assistencials, Badalona, Barcelona, Spain
    Bipolar Disord 10:607-16. 2008
    ..To estimate the prevalence of metabolic syndrome (MS) in patients with bipolar disorder (BD) included in a Health Management Organization (HMO) database...
  45. ncbi request reprint Cross-sectional evaluation of patient functioning and health-related quality of life in patients with neuropathic pain under standard care conditions
    Rafael Galvez
    Pain and Palliative Care Unit, Hospital Universitario Virgen de las Nieves, Unidad de dolor y Cuidados Paliativos, Avda de las Fuerzas Armadas, 2, 18014 Granada, Spain
    Eur J Pain 11:244-55. 2007
    ..The purpose of this cross-sectional evaluation was to determine the impact of neuropathic pain (NeP) on patient functioning and Health-Related Quality of Life (HRQoL) under standard care conditions...
  46. ncbi request reprint [Linguistic adaptation and Spanish validation of the LANSS (Leeds Assessment of Neuropathic Symptoms and Signs) scale for the diagnosis of neuropathic pain]
    Concepcion Perez
    Unidad del Dolor Hospital de la Princesa Madrid España
    Med Clin (Barc) 127:485-91. 2006
    ..This study was intended to achieve a linguistic adaptation and validation into Spanish of the LANNS scale for the differential diagnosis of neuropathic pain...
  47. ncbi request reprint Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study
    Julio Bobes
    Medicine Department, Psychiatry Area, University of Oviedo, Asturias, Spain
    Schizophr Res 90:162-73. 2007
    ..To assess the prevalence of Coronary Heart Disease (CHD) and Metabolic Syndrome (MS) in patients treated with antipsychotics...
  48. ncbi request reprint Cost-effectiveness analysis of schizophrenia relapse prevention : an economic evaluation of the ZEUS (Ziprasidone-Extended-Use-In-Schizophrenia) study in Spain
    Miguel Bernardo
    Department of Psychiatry, Hospital Clinic i Provincial, Barcelona, Spain
    Clin Drug Investig 26:447-57. 2006
    ..The aim of this study was to estimate the cost-effectiveness of schizophrenia relapse prevention in Spain using data from the ZEUS (Ziprasidone-Extended-Use-in-Schizophrenia) study...
  49. ncbi request reprint Cognitive function impairment in patients with neuropathic pain under standard conditions of care
    Monica Povedano
    Department of Neurology, Hospital Universitario de Bellvitge, L Hospitalet de Llobregat, Barcelona, Spain
    J Pain Symptom Manage 33:78-89. 2007
    ..Age, anxiety, depression, and obesity were factors found to be significantly associated with CI...
  50. ncbi request reprint Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S): psychometric properties of a brief scale for cognitive evaluation in schizophrenia
    Oscar Pino
    Department of Psychiatry, Hospital General Granollers Benito Menni CASM, Granollers, Barcelona, Spain
    Schizophr Res 99:139-48. 2008
    ..This study examined the psychometric properties of the Spanish version of the SCIP in a sample of outpatients suffering schizophrenia-spectrum disorders...
  51. ncbi request reprint [Adaptation and validation of the Health Utilities Index Mark 3 into Spanish and correction norms for Spanish population]
    Miguel Ruiz
    Departamento de Metodología Facultad de Psicología Universidad Autónoma de Madrid Madrid Spain
    Med Clin (Barc) 120:89-96. 2003
    ..We present its Spanish adaptation and validation. Moreover, we estimate its utility in the Spanish population and compare it to Canadian patients...
  52. ncbi request reprint Development and validation of the Migraine Screen Questionnaire (MS-Q)
    Miguel J A Láinez
    Hospital Clinico Universitario, Universidad de Valencia, Neurology Department, Spain
    Headache 45:1328-38. 2005
    ..To develop and evaluate the clinimetric properties of a new migraine screening questionnaire: the Migraine Screen Questionnaire (MS-Q)...
  53. ncbi request reprint [Prevalence of neuropathic pain in Spain: clinical, working and health care implications]
    Rafael Galvez
    Unidad del Dolor y Cuidados Paliativos, Hospital Universitario Virgen de las Nieves, Granada, Spain
    Med Clin (Barc) 125:221-9. 2005
    ..NP is a diverse and highly prevalent condition in Spain. Efforts should be conducted towards the achievement of diagnostic criteria consensus and higher rates of analgesic success...